Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cells

Area of Science:

• Biochemistry
• Cell Biology
• Cancer Research

Background:

• Proteoglycans, modified proteins with glycosaminoglycan chains, are key in biological processes.
• Chondroitin sulfate proteoglycans (CSPGs) show promise as drug-delivery targets in cancer therapy.
• Understanding CSPG internalization mechanisms in tumor cells is crucial for therapeutic development.

Purpose of the Study:

• To investigate the internalization pathways and intracellular fate of CSPGs within tumor cells.
• To utilize a recombinant CSPG-binding lectin, VAR2CSA (rVAR2), as a tool to track CSPG uptake and trafficking.
• To elucidate the role of chondroitin sulfate in the cellular processing of bound molecules.

Main Methods:

• Employing recombinant VAR2CSA (rVAR2) to bind and track cell surface CSPGs on cancer cells.
• Analyzing internalization mechanisms, including endocytosis pathways.
• Investigating the intracellular trafficking of CSPG-bound rVAR2 using cell biology techniques.
• Characterizing the release of internalized complexes via exosome secretion.

Main Results:

• rVAR2 binds to cell surface CSPGs and is internalized into cancer cells through multiple mechanisms.
• Internalized CSPG-bound rVAR2 is trafficked to early endosomes in an energy-dependent manner.
• The lysosomal pathway is not involved in the degradation of CSPG-bound rVAR2.
• Internalized CSPG-bound rVAR2 is secreted extracellularly via exosomes, dependent on chondroitin sulfate.

Conclusions:

• The study details the cellular fate of rVAR2 bound to CSPGs in tumor cells.
• Internalization and exosomal secretion of CSPG-bound rVAR2 occur via specific, non-degradative pathways.
• Findings provide a foundation for developing novel therapeutics, such as rVAR2-drug conjugates, targeting CSPGs in cancer.